Literature DB >> 29582587

Disrupted striatal neuron inputs and outputs in Huntington's disease.

Anton Reiner1,2, Yun-Ping Deng1.   

Abstract

Huntington's disease (HD) is a hereditary progressive neurodegenerative disorder caused by a CAG repeat expansion in the gene coding for the protein huntingtin, resulting in a pathogenic expansion of the polyglutamine tract in the N-terminus of this protein. The HD pathology resulting from the mutation is most prominent in the striatal part of the basal ganglia, and progressive differential dysfunction and loss of striatal projection neurons and interneurons account for the progression of motor deficits seen in this disease. The present review summarizes current understanding regarding the progression in striatal neuron dysfunction and loss, based on studies both in human HD victims and in genetic mouse models of HD. We review evidence on early loss of inputs to striatum from cortex and thalamus, which may be the basis of the mild premanifest bradykinesia in HD, as well as on the subsequent loss of indirect pathway striatal projection neurons and their outputs to the external pallidal segment, which appears to be the basis of the chorea seen in early symptomatic HD. Later loss of direct pathway striatal projection neurons and their output to the internal pallidal segment account for the severe akinesia seen late in HD. Loss of parvalbuminergic striatal interneurons may contribute to the late dystonia and rigidity.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Huntington's disease; corticostriatal; interneurons; pathology; premanifest; projection neurons; striatum; thalamostriatal

Mesh:

Year:  2018        PMID: 29582587      PMCID: PMC5875736          DOI: 10.1111/cns.12844

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  332 in total

1.  Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease.

Authors:  H Heinsen; U Rüb; D Gangnus; G Jungkunz; M Bauer; G Ulmar; B Bethke; M Schüler; F Böcker; W Eisenmenger; M Götz; M Strik
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

3.  TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons.

Authors:  Maryna Baydyuk; Theron Russell; Guey-Ying Liao; Keling Zang; Juan Ji An; Louis French Reichardt; Baoji Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

4.  Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum.

Authors:  Q Chen; L Veenman; K Knopp; Z Yan; L Medina; W J Song; D J Surmeier; A Reiner
Journal:  Neuroscience       Date:  1998-04       Impact factor: 3.590

5.  Selective sparing of a class of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; E P Richardson; E D Bird; J B Martin
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

6.  The striatopallidal and striatonigral projections: two distinct fiber systems in primate.

Authors:  A Parent; C Bouchard; Y Smith
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

7.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.

Authors:  D Dawbarn; M E De Quidt; P C Emson
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

8.  Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.

Authors:  Ilse Gantois; Ke Fang; Luning Jiang; Daniela Babovic; Andrew J Lawrence; Vincenzo Ferreri; Yaroslav Teper; Bianca Jupp; Jenna Ziebell; Cristina M Morganti-Kossmann; Terence J O'Brien; Rachel Nally; Günter Schütz; John Waddington; Gary F Egan; John Drago
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

Review 9.  Normal huntingtin function: an alternative approach to Huntington's disease.

Authors:  Elena Cattaneo; Chiara Zuccato; Marzia Tartari
Journal:  Nat Rev Neurosci       Date:  2005-12       Impact factor: 34.870

Review 10.  Corticostriatal Dysfunction in Huntington's Disease: The Basics.

Authors:  Kendra D Bunner; George V Rebec
Journal:  Front Hum Neurosci       Date:  2016-06-28       Impact factor: 3.169

View more
  30 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu u Imaging of Cortical Afferents in the Striatum of Normal and Huntington (Q175) Mice.

Authors:  Anton Dvorzhak; Nordine Helassa; Katalin Török; Dietmar Schmitz; Rosemarie Grantyn
Journal:  J Neurosci       Date:  2019-02-28       Impact factor: 6.167

3.  Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.

Authors:  Svitlana Yablonska; Vinitha Ganesan; Lisa M Ferrando; JinHo Kim; Anna Pyzel; Oxana V Baranova; Nicolas K Khattar; Timothy M Larkin; Sergei V Baranov; Ning Chen; Colleen E Strohlein; Donté A Stevens; Xiaomin Wang; Yue-Fang Chang; Mark E Schurdak; Diane L Carlisle; Jonathan S Minden; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

4.  Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.

Authors:  Sandra M Holley; Laurie Galvan; Talia Kamdjou; Carlos Cepeda; Michael S Levine
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

Review 5.  The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington's Disease.

Authors:  Abraham Rosas-Arellano; Argel Estrada-Mondragón; Ricardo Piña; Carola A Mantellero; Maite A Castro
Journal:  Int J Mol Sci       Date:  2018-08-14       Impact factor: 5.923

Review 6.  Timing behavior in genetic murine models of neurological and psychiatric diseases.

Authors:  Ayşe Karson; Fuat Balcı
Journal:  Exp Brain Res       Date:  2021-01-06       Impact factor: 1.972

Review 7.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

8.  Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses.

Authors:  Kirby M Donnelly; Olivia R DeLorenzo; Aprem DA Zaya; Gabrielle E Pisano; Wint M Thu; Liqun Luo; Ron R Kopito; Margaret M Panning Pearce
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

Review 9.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

10.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.